Extension Study for 43USSA1705
Completed · Not applicable
Conditions studied: Nasolabial Folds
In brief
To evaluate the long-term safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.
Key facts
- Study ID
- NCT04225273
- Run by
- Galderma R&D
- People needed
- 38
- Starts
- 2019-12-03
- Expected to finish
- 2021-01-29
- Last updated by the study team
- 2025-03-12
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Randomized to Sculptra Aesthetic 8ml reconstitution and successfully completed study 43USSA1705
You may not qualify if…
- Medical condition that in the opinion of the Investigator would make the subject unsuitable for inclusion
- Other condition preventing the subject from entering the study in the Investigator's opinion
- Participation in any interventional clinical study throughout the duration of the study
Where it is running
- Galderma Study Site — Scottsdale, Arizona, United States
- Galderma Study Site — Bradenton, Florida, United States
- Galderma Study Site — Austin, Texas, United States
- Galderma Study Site — Spring, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.